Path: utzoo!utgpu!watserv1!watmath!uunet!bionet!ig!presto.ig.com!dow
From: dow@presto.ig.com (Christopher Dow)
Newsgroups: bionet.molbio.bio-matrix
Subject: Re: A LITTLE LIFE!!!
Message-ID: <Feb.14.15.43.20.1991.2821@presto.ig.com>
Date: 14 Feb 91 23:43:20 GMT
References: <BEBBF12974DF20023B@chemf.rutgers.edu>
Sender: news@presto.ig.com
Reply-To: dow@presto.ig.com (Christopher Dow)
Organization: IntelliGenetics, Inc.
Lines: 19
Nntp-Posting-Host: presto.ig.com

In article <BEBBF12974DF20023B@chemf.rutgers.edu>,
MARLA@CHEMF.RUTGERS.EDU writes:
> 
> 	Let's face it, the rub is too little money, so good grants are
> getting turned down in some reasearch areas, while less qualified
> grants put into a 'privileged' project such, as the human genome
> project get funded.
	Correct me if I'm wrong, but the last I heard (from a 
reliable source) was that the 'priveledged' project was AIDS research
which at one time (and maybe even still) recieved more money than 
cancer research, although it kills less people.

> 			No insults Please.
	None intended.

Chris Dow                             IntelliGenetics
Software Engineer                     700 East El Camino Real
icbmnet: 37 22' 39" N, 122 3' 32" W   Mountain View, Ca. 94040
dow@presto.ig.com                     (415) 962-7320